Nathan Robert Handley MD MBA

PubMed

• Prostein expression on circulating tumor cells as a prognostic marker in metastatic castration-resistant prostate cancer.
  Zhenchao Zhang, Rui Luo, William K Kelly, Joshua Chen, Shane Donahue
  Prostate Cancer and Prostatic Diseases. 2024-06-01
• 1 citations
  TARGET: A Randomized, Noninferiority Trial of a Pretest, Patient-Driven Genetic Education Webtool Versus Genetic Counseling for Prostate Cancer Germline Testing.
  Stacy Loeb, Scott W Keith, Heather H Cheng, Amy E Leader, Laura Gross
  JCO Precision Oncology. 2024-03-01
• Hematologic Malignancy Episodes Exceed Target Price in Oncology Care Model.
  Jennifer Nguyen, Vittorio Maio, Karen Walsh, Nathan Handley, Shivangi Patel
  American Journal of Medical Quality. 2023-06-15

Journal Articles

• Medical Oncology Professionals’ Perceptions of Telehealth Video Visits  
  Nathan Handley, MD, JAMA Network Open
• Liver Metastasis and Treatment Outcome with Anti-PD-1 Monoclonal Antibody in Patients with Melanoma and NSCLC  
  Tumeh, P., Hellman, M., Hamid, O., Tsai, K., Loo, K., Gubens, M., Rosenblum, M., Harview, C., Taube, J., Handley, N et al, Cancer Immunology Research, 1/1/2017
• PPAR gamma targeted oral cancer treatment and additional utility of genomics analytic techniques  
  Handley, N., Eide, J., Taylor, R., Wuertz, B., Gaffney, P. and Ondrey, F, The Laryngoscope, 1/1/2017
• Specialty Care Access in the Safety Net - the Role of Public Hospitals and Health Systems  
  Makaroun, L. K., Bowman, C., Duan, K., Handley, N., Wheeler, D. J., Pierluissi, E., & Chen, A. H, Journal of Health Care for the Poor and Underserved, 1/1/2017
• Antibiotic overuse and paronychia  
  Handley N and Unger A, JAMA Intern Med, 1/16/2015
• Join now to see all

Abstracts/Posters

• A Novel Platform for the Management and Dissemination of Clinical Trials.
  Handley N and Leri D, The 27th Annual Mayo Clinic Hematology Oncology Reviews, Amelia Island, FL, 1/17/2017
• Optimizing Access to Outpatient Specialty Care in the Safety Net: A Nationwide Survey.
  Bowman C, Duan K, Handley N, Makaroun L, Wheeler D, Chen A, Pierluissi E, Society of General Internal Medicine 38th Annual Meeting, Toronto, ON, Canada, 1/1/2015
• Abstract 2857: Metastatic site and response to pembrolizumab (anti-PD1 antibody) in melanoma.
  Tumeh PC, Rosenblum M, Handley N, Tsai K, Rodriguez R, Khurana N, Harview C, Spasic M, Sanchez PJ, Chang J, Shintaku P, Taylor E, Chmielowski B, Grogan T, Elashoff DA,..., Cancer Res, 1/1/2015
• Identification of Pro-Differentiation Patterns by Gene Expression Analysis following Pioglitazone Treatment in a Primary Laryngeal Tumor Cell Line.
  Handley NR, Gaffney PM, Taylor RS, Wuertz BR, Ondrey FG, The Combined Otolaryngology Spring Meeting, Chicago, IL, 1/27/2011
• Join now to see all

Lectures

• An Atypical Illness: Cognitive Biases in Neutropenic Sepsis. 
  Philadelphia, PA - 1/20/2017
• Innovation in Health Care: Digital Health, Disruption, and the Role of Insiders. 
  San Francisco, CA - 1/19/2017
• Innovation at the Point of Care: Improving Access to Clinical Trials. 
  Philadelphia, PA - 1/11/2017
• Strategies for Reducing Unplanned Acute Care in Cancer. 
  Abramson Cancer Center, Philadelphia, PA - 1/6/2017
• Cases from Ilula District Hospital in Ilula, Tanzania. 
  Minneapolis, MN - 1/20/2011
• PPAR gamma mediated involucrin induction in aerodigestive preneoplasia in vitro. 
  Orlando, FL - 1/2/2011
• Join now to see all

Other

• Hematology and Oncology 
  Handley N, Schoenfeld A, Narayana S, UCSF Hospitalist Handbook
  San Francisco, CA